Cefotaxime treatment for women with community-acquired pelvic abscesses

David L. Hemsell, Rigoberto Santos-Ramos, F. Gary Cunningham, Brenda J. Nobles, Patricia G. Hemsell

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Forty-one women with pelvic abscesses complicating salpingitis were treated with parenteral cefotaxime, a newer cephalosporin. Abscesses ranged in size from 4 by 4 to 13 by 15 cm, and in 10 women (24%) they were ≥10 cm. Neisseria gonorrhoeae was recovered from the endocervix in 17 women (41%). A mean of 26.7 gm of cefotaxime was given over a mean of 6.5 days, and operation was not required during initial therapy. Only two women (5%) required the addition of another antimicrobial. Chronic pelvic pain and recurrent infection were infrequent during the 31- to 43-month follow-up period. Five women (12%) were readmitted for elective surgical therapy because of persistent or recurrent adnexal mass 1 to 33 months following study entry. Six (15%) women became pregnant and were delivered of their infants a mean of 25 months following cefotaxime therapy.

Original languageEnglish (US)
Pages (from-to)771-777
Number of pages7
JournalAmerican journal of obstetrics and gynecology
Issue number6
StatePublished - Mar 15 1985


  • Salpingitis
  • cefotaxime
  • pelvic abscess

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Cefotaxime treatment for women with community-acquired pelvic abscesses'. Together they form a unique fingerprint.

Cite this